Alto Neuroscience, Inc. ANRO

26.49 (0.69) (2.54%) as of 25 Sep
Market cap
$1.1B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
243.73 263.76 176.48 137.82

+8 more quarters

Total current assets
247.32 269.13 177.72 139.45
Property, Plant, Equpment (Net)
2.05 2.23 1.87 2.03
Long-term assets (Other)
0.84 0.84 0.84 1.07
Total non-current assets
6.75 7.13 6.97 7.56
Total Assets
254.07 276.26 184.69 147.01
Accounts Payable
4.02 3.37 1.88 2.06
Accrued Expenses
8.86 7.61 8.86 6.99
Current Part of Debt
3.77 2.14 0.59 —
Total current liabilities
16.65 13.12 11.33 9.05
Long Term Debt (Total)
14.88 16.22 18.40 22.44
Total non-current liabilities
18.17 19.78 22.22 26.40
Total liabilities
34.82 32.89 33.55 35.45
Additional Paid In Capital
474.74 471.22 352.75 296.99
Common Stock (Net)
0.00 0.00 0.00 0.00
Retained Earnings
(255.51) (227.87) (201.63) (185.45)
Common Equity (Total)
219.25 243.37 151.14 111.56
Shareholders Equity (Total)
219.25 243.37 151.14 111.56
Shareholders Equity and Liabilities (Total)
254.07 276.26 184.69 147.01
Shares (Common)
35.09 35.05 31.92 27.17
Shareholders Equity (Tangible)
219.25 243.37 151.14 111.56
Net Debt
(225.08) (245.41) (157.50) (115.38)
Total Debt
18.65 18.36 18.98 22.44

Fold the line items

In millions of $ except per-share values · columns are period end dates